|Related Categories||Alkaloids, Alphabetical Index of Analytical Standards, Analytical Standards, Analytical/Chromatography, Chemical Structure,|
|drug control||USDEA Schedule II; Home Office Schedule 2; stupéfiant; kontrollierte Droge in Deutschland; regulated under CDSA - not available from Sigma-Aldrich Canada|
μ and κ opioid receptor agonist.
Certificate of Analysis
Certificate of Origin
Composite measure to assess efficacy/gastrointestinal tolerability of tapentadol ER versus oxycodone CR for chronic pain: pooled analysis of randomized studies. Merchant S, Provenzano D, Mody S, et al. J. Opioid Manag. 9(1), 51-61, (2013)
Controlled-release oxycodone and naloxone in the treatment of chronic low back pain: a placebo-controlled, randomized study. Cloutier C, Taliano J, O'Mahony W, et al. Pain Res. Manag. 18(2), 75-82, (2013)
Ask the doctors. I have had back problems for decades, and I have become quite dependent on oxycodone, regardless of whether my back is acting up or not. Now I am going to need heart surgery, but the surgeon I was sent to won't operate unless I can get off the pain pills. That seems cruel. What is he thinking? Lee T and Lee R Harv. Heart Lett. 23(4), 2, (2012)
A comparison of oxycodone prolonged-release vs. oxycodone + naloxone prolonged-release after laparoscopic hysterectomy. Comelon M, Wisloeff-Aase K, Raeder J, et al. Acta Anaesthesiol. Scand. 57(4), 509-17, (2013)
Self-assembly of thermally responsive nanoparticles of a genetically encoded peptide polymer by drug conjugation. McDaniel JR, Bhattacharyya J, Vargo KB, et al. Angew. Chem. Int. Ed. Engl. 52(6), 1683-7, (2013)
Reduced antinociception of opioids in rats and mice by vaccination with immunogens containing oxycodone and hydrocodone haptens. Pravetoni M, Le Naour M, Tucker AM, et al. J. Med. Chem. 56(3), 915-23, (2013)
Assessing subjective and physiologic effects following intranasal administration of a new formulation of immediate release oxycodone HCl (Oxecta™) tablets in nondependent recreational opioid users. Schoedel KA, Rolleri RL, Faulknor JY, et al. J. Opioid Manag. 8(5), 315-27, (2012)
A poor metabolizer of both CYP2C19 and CYP2D6 identified by mechanistic pharmacokinetic simulation in a fatal drug poisoning case involving venlafaxine. Jornil J, Nielsen TS, Rosendal I, et al. Forensic Sci. Int. 226(1-3), e26-31, (2013)
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Need larger quantities for your development, manufacturing or research applications?